GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LBX Pharmacy Chain JSC (SHSE:603883) » Definitions » Beneish M-Score

LBX Pharmacy Chain JSC (SHSE:603883) Beneish M-Score : -2.50 (As of Apr. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is LBX Pharmacy Chain JSC Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.5 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for LBX Pharmacy Chain JSC's Beneish M-Score or its related term are showing as below:

SHSE:603883' s Beneish M-Score Range Over the Past 10 Years
Min: -2.96   Med: -2.51   Max: -1.73
Current: -2.5

During the past 12 years, the highest Beneish M-Score of LBX Pharmacy Chain JSC was -1.73. The lowest was -2.96. And the median was -2.51.


LBX Pharmacy Chain JSC Beneish M-Score Historical Data

The historical data trend for LBX Pharmacy Chain JSC's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBX Pharmacy Chain JSC Beneish M-Score Chart

LBX Pharmacy Chain JSC Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.54 -2.57 -2.73 -2.55 -2.51

LBX Pharmacy Chain JSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.53 -2.51 -2.73 -2.72 -2.50

Competitive Comparison of LBX Pharmacy Chain JSC's Beneish M-Score

For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBX Pharmacy Chain JSC's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where LBX Pharmacy Chain JSC's Beneish M-Score falls into.



LBX Pharmacy Chain JSC Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of LBX Pharmacy Chain JSC for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9661+0.528 * 1.0091+0.404 * 0.9833+0.892 * 1.2336+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9177+4.679 * -0.044493-0.327 * 0.9975
=-2.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep22) TTM:
Total Receivables was ¥2,342 Mil.
Revenue was 5230.667 + 5370.345 + 5440.516 + 6399.096 = ¥22,441 Mil.
Gross Profit was 1676.269 + 1742.316 + 1795.335 + 1914.472 = ¥7,128 Mil.
Total Current Assets was ¥8,939 Mil.
Total Assets was ¥21,325 Mil.
Property, Plant and Equipment(Net PPE) was ¥4,540 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥4,654 Mil.
Total Current Liabilities was ¥10,577 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,445 Mil.
Net Income was 203.315 + 221.912 + 291.334 + 175.339 = ¥892 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 392.159 + 187.88 + 849.192 + 411.482 = ¥1,841 Mil.
Total Receivables was ¥1,965 Mil.
Revenue was 4785.357 + 4850.416 + 4140.65 + 4415.286 = ¥18,192 Mil.
Gross Profit was 1576.038 + 1519.912 + 1420.939 + 1314.39 = ¥5,831 Mil.
Total Current Assets was ¥7,845 Mil.
Total Assets was ¥20,268 Mil.
Property, Plant and Equipment(Net PPE) was ¥4,839 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥4,111 Mil.
Total Current Liabilities was ¥9,228 Mil.
Long-Term Debt & Capital Lease Obligation was ¥4,134 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2341.593 / 22440.624) / (1964.834 / 18191.709)
=0.104346 / 0.108007
=0.9661

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(5831.279 / 18191.709) / (7128.392 / 22440.624)
=0.320546 / 0.317656
=1.0091

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (8939.207 + 4539.69) / 21325.004) / (1 - (7844.693 + 4839.397) / 20268.37)
=0.36793 / 0.374193
=0.9833

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=22440.624 / 18191.709
=1.2336

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 4839.397)) / (0 / (0 + 4539.69))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4654.468 / 22440.624) / (4111.417 / 18191.709)
=0.207413 / 0.226005
=0.9177

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3445.284 + 10577.075) / 21325.004) / ((4133.51 + 9227.542) / 20268.37)
=0.657555 / 0.659207
=0.9975

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(891.9 - 0 - 1840.713) / 21325.004
=-0.044493

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

LBX Pharmacy Chain JSC has a M-score of -2.50 suggests that the company is unlikely to be a manipulator.


LBX Pharmacy Chain JSC Beneish M-Score Related Terms

Thank you for viewing the detailed overview of LBX Pharmacy Chain JSC's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


LBX Pharmacy Chain JSC (SHSE:603883) Business Description

Traded in Other Exchanges
N/A
Address
No. 288, Xiangya Road, Kaifu District, Hunan, Changsha, CHN, 410005
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.

LBX Pharmacy Chain JSC (SHSE:603883) Headlines

No Headlines